Evidence map›Paper›PMID 37820366›Full record

ArticleEuropean journal of ophthalmology2024

Epiretinal implant of human amniotic membrane to treat highly myopic macular hole retinal detachments: A novel surgical technique.

Danilo Iannetta, Jay Chhablani, Nicola Valsecchi, Maria Mesiani, Marc D de Smet, Luigi Fontana

Open access · hybridAbstract read
In one paragraph

Article in European journal of ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Danilo IannettaIRCCS Azienda Ospedaliero-Universitaria di Bologna.ORCID 0000-0002-8532-4578
Jay ChhablaniMedical Retina and Vitreoretinal Surgery, University of Pittsburgh School of Medicine, 203 Lothrop Street, Suite 800, 15213 Pittsburgh, PA, USA.ORCID 0000-0001-8932-5343
Nicola ValsecchiIRCCS Azienda Ospedaliero-Universitaria di Bologna.ORCID 0000-0002-3887-7655
Maria MesianiIRCCS Azienda Ospedaliero-Universitaria di Bologna.
Marc D de SmetHelvetia Retina Associates, Micro Invasive Ocular Surgery Center, Av du Léman 32, Lausanne, Switzerland.ORCID 0000-0002-9217-5603
Luigi FontanaIRCCS Azienda Ospedaliero-Universitaria di Bologna.
Azienda USL di Bologna · ITUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe a new surgical technique involving the use of a human amniotic membrane (hAM) epiretinal patch to treat a primary macular hole retinal detachment (MHRD) in a highly myopic patient.

methodsA 60 years old highly myopic man was referred to our clinic with a diagnosis of MHRD in his right eye. The patient was pseudophakic, with a visual acuity of counting fingers at the baseline evaluation. Pars plana vitrectomy was performed, a small retinotomy was created at the inner margin of the staphyloma, and membrane blue dual was used to obtain an adequate peeling of the inner limiting membrane. Then, a 1.5 mm diameter circular hAM patch was obtained and positioned over the macular hole with the chorion layer settled over the retina. After a complete fluid-air exchange, 20% sulfur hexafluoride gas was used as endotamponade, and the patient was asked to remain face down for three days.

resultsFour weeks after surgery, optical coherence tomography (OCT) scan showed the hAM patch, visualized as a distinct hyperreflective layer well integrated with the retina. Nine months after surgery, the macular hole was closed, the retina reattached, the hAM patch was adherent to the retina, and the patient presented a best-corrected visual acuity improved to 0.7 logMar. No postoperative adverse events were registered during the follow-up.

conclusionsEpiretinal hAM implant could represent a novel surgical technique, feasible and easier compared to other current techniques used to treat MHRD in highly myopic patients.

Indexed as

Epiretinal MembraneMyopiaRetinal DetachmentRetinal PerforationsAmnionHumansMaleMiddle AgedRetrospective StudiesTomography, Optical CoherenceVitrectomyAmniotic membrane implantlarge macular holemacular detachmentmacular holesmyopiavitreous surgery

Identifiers

PMID37820366
PMCPMC11046140
OpenAlexW4387521997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.